CharlesJohnBillingtonMDPhD, FACMG, FAAP

Medical Genetics • Minneapolis, MN

Clinical Genetics, Medical Biochemical Genetics

Genetics and Metabolism, Assistant Professor

Join to view full profile

Dr. Billington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Billington's full profile

Already have an account?

Office
4-150 Moos Tower, MMC 75 Billington Jr.
420 Delaware St SE
Minneapolis, MN 55455
Is this information wrong?

Summary

Dr. Charles Billington is a pediatrician in Minneapolis, MN, He received his medical degree from University of Minnesota Medical School. He specializes in medical genetics.

Education & Training

Children's National Medical CenterResidency, Pediatrics, 2014 - 2017
University of Minnesota Medical SchoolClass of 2014

Certifications & Licensure

WI State Medical License 2021 - 2025
MN State Medical License 2020 - 2025
DC State Medical License 2016 - 2020
American Board of Medical Genetics and Genomics Medical Biochemical Genetics
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Publications & Presentations

PubMed

Neuromodulation of orexin neurons reduces diet-induced adiposity.
Zink, A. N.,Bunney, P. E.,Holm, A. A.,Billington, C. J.,Kotz, C. M.> ;Int J Obes (Lond). 2017 Nov 29
15 citations
National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study ...
Keong Chong, Sayeed Ikramuddin, Wei-Jei Lee, Charles J. Billington, John P. Bantle, Qi Wang, Avis J. Thomas, John E. Connett, Daniel B. Leslie, William B. Inabnet, Rob...> ;Obesity Surgery. 2017 May 1
22 citations
Exome analysis of Smith–Magenis-like syndrome cohort identifies de novo likely pathogenic variants
Seth I. Berger, Carla Ciccone, Karen L. Simon, May Christine V. Malicdan, Thierry Vilboux, Charles J. Billington, Roxanne Fischer, Wendy J. Introne, Andrea L. Gropman,...> ;Human Genetics. 2017 Feb 17
Diabetes Prevention Program Translation in the Veterans Health Administration.
Moin, T.,Damschroder, L. J.,AuYoung, M.,Maciejewski, M. L.,Datta, S. K.,Weinreb, J. E.,Steinle, N. I.,Billington, C.,Hughes, M.,Makki, F.,Holleman, R. G.,Kim, H. M.,Je...> ;Am J Prev Med. 2017 Jan 18
Orexin signaling in rostral lateral hypothalamus and nucleus accumbens shell in the control of spontaneous physical activity in high and low activity rats.
Perez-Leighton CE, Little MR, Grace MK, Billington CJ, Kotz CM> ;Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2016-12-30
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabet...
Ikramuddin S, Korner J, Lee W, Bantle JP, Thomas AJ, Connett JE, Leslie DB, Inabnet WB, Wang Q, Jeffery RW, Chong K, Chuang L, Jensen MD, Vella A, Ahmed L, Belani K, O...> ;Diabetes Care. 2016-09-01
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial.
Apovian CM, Shah SN, Wolfe BM, Ikramuddin S, Miller CJ, Tweden KS, Billington CJ, Shikora SA> ;Obes Surg. 2016-08-10
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
Sachdev, S.,Wang, Q.,Billington, C.,Connett, J.,Ahmed, L.,Inabnet, W.,Chua, S.,Ikramuddin, S.,Korner, J.> ;Obes Surg. 2015 Aug 12
Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results...
Shikora, S. A.,Toouli, J.,Herrera, M. F.,Kulseng, B.,Brancatisano, R.,Kow, L.,Pantoja, J. P.,Johnsen, G.,Brancatisano, A.,Tweden, K. S.,Knudson, M. B.,Billington, C. J...> ;Obes Surg. 2015 Oct 17
30 citations
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study.
Morton, J. M., Morton, J. M., Shah, S. N., Shah, S. N., Wolfe, B. M., Wolfe, B. M., Apovian, C. M., Apovian, C. M., Miller, C. J., Miller, C. J., Tweden, K. S., Tweden...> ;Obesity surgery. 2016 Apr 7
Erratum to: Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-...
Shikora, S. A.,Toouli, J.,Herrera, M. F.,Kulseng, B.,Brancatisano, R.,Kow, L.,Pantoja, J. P.,Johnsen, G.,Brancatisano, A.,Tweden, K. S.,Knudson, M. B.,Billington, C. J.> ;Obes Surg. 2015 Nov 04
Role of orexin A signaling in dietary palmitic acid-activated microglial cells.
Duffy CM, Yuan C, Wisdorf LE, Billington CJ, Kotz CM, Nixon JP, Butterick TA> ;Neurosci. Lett.. 2015-10-08
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastri...
Nguyen KT, Billington CJ, Vella A, Wang Q, Ahmed L, Bantle JP, Bessler M, Connett JE, Inabnet WB, Thomas A, Ikramuddin S, Korner J> ;Diabetes. 2015-09-01
134 citations
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
Ikramuddin, S., Billington, C. J., Lee, W., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Jeffery, R. W., Chong, K., Chuang, L., Sarr, M...> ;The lancet. Diabetes & endocrinology. 2015 May 17
36 citations
Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.
Damschroder, L. J., Moin, T., Datta, S. K., Reardon, C. M., Steinle, N. I., Weinreb, J., Billington, C. J., Maciejewski, M. L., Yancy, W. S., Hughes, M., Makki, F., Ri...> ;Implementation science : IS. 2015 May 13
The Function of Twisted Gastrulation in Regulating Osteoclast Differentiation is Dependent on BMP Binding.
Huntley, R.,Davydova, J.,Petryk, A.,Billington, C. J.,Jensen, E. D.,Mansky, K. C.,Gopalakrishnan, R.> ;J. Cell. Biochem.. 2015 Mar 27
Impact of retinoic acid exposure on midfacial shape variation and manifestation of holoprosencephaly in Twsg1 mutant mice.
Billington, C. J.,Schmidt, B.,Marcucio, R. S.,Hallgrimsson, B.,Gopalakrishnan, R.,Petryk, A.> ;Dis Model Mech. 2014 Dec 04
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial.
Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD, Ikramuddin S, Miller CJ, Knudson MB, Tweden KS, Sarr MG, Billington CJ> ;J Obes. 2015-01-01
75 citations
Sleep disorders, obesity, and aging: the role of orexin.
Nixon, J. P., Mavanji, V., Butterick, T. A., Billington, C. J., Kotz, C. M., Teske, J. A.> ;Ageing research reviews. 2014 Dec 3
Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure.
Noble EE, Billington CJ, Kotz CM, Wang C> ;Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2014-09-15
141 citations
Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: The ReCharge randomized clinical trial
Sayeed Ikramuddin, Robin P. Blackstone, Anthony Brancatisano, James Toouli, Sajani Shah, Bruce M. Wolfe, Ken Fujioka, James W. Maher, James M. Swain, Florencia G. Que,...> ;JAMA. 2014 Sep 3
Role of spontaneous physical activity in prediction of susceptibility to activity based anorexia in male and female rats.
Perez-Leighton, C.,Grace, M.,Billington, C. J.,Kotz, C. M.> ;Physiol. Behav.. 2014 Jun 10
Exercise reduces diet-induced cognitive decline and increases hippocampal brain-derived neurotrophic factor in CA3 neurons.
Noble, E. E.,Mavanji, V.,Little, M. R.,Billington, C. J.,Kotz, C. M.,Wang, C.> ;Neurobiol Learn Mem. 2014 Apr 24
Methodological considerations for measuring spontaneous physical activity in rodents.
Teske, J. A.,Perez-Leighton, C. E.,Billington, C. J.,Kotz, C. M.> ;Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2014 Mar 07
Orexin modulation of adipose tissue.
Perez-Leighton, C. E.,Billington, C. J.,Kotz, C. M.> ;Biochim. Biophys. Acta. 2013 Jun 25
Join now to see all

Press Mentions

ReShape Lifesciences Presents New Data on Proprietary Technology for Type 2 DiabetesNovember 26th, 2018
Weight-Loss Surgery's Benefits Wane over Time for DiabeticsJanuary 19th, 2018
Is Overeaters Anonymous an Alternative to Bariatric Surgery?November 4th, 2017
Join now to see all

Grant Support

Enhancing NEAT To Treat ObesityVeterans Affairs2012
Neuropeptide Y--Effects On Energy MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1991–2001
Neuropeptide Y--Effects On Energy MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1996

Hospital Affiliations

M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota